Filing Flows

Filing Flows › Technology › Bio Key International (BKYI)

Bio Key International (BKYI) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Bio Key International (BKYI) Q2 2026 earnings results →

Q2 2026 Revenue up 13% year over year to $1.9M · 30¢ of every $1 of revenue lost · operating margin -27.6%

Bio Key International made $1.9M in Q2 2026 (+13% Y/Y): License $1.2M, Hardware $460K, Service $231K. Operating margin -27.6%, net loss $577K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.

Revenue$1.9M
Year over year+13%
Operating margin-27.6%
Net earnings−$577K
Operating cash flow−$846K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $1.9M in Q2 2026, up 13% year over year and down 11% from the previous quarter. License was the largest line at 64% of revenue. License added $423K year over year (up 53%), 190% of the total change. Service declined 28%.

Gross margin was 87.2%, up 14.5 points from Q2 2025. Operating costs exceeded revenue by $529K, an operating margin of -27.6%. Operating expenses fell 5% while revenue rose 13%. The quarter ended with a net loss of $577K, wider than the previous quarter's $205K loss.

Operating cash flow was −$846K. Non-cash charges added back $74K of depreciation and amortization and $43K of share-based compensation. Working capital and other items used $386K.

Quarterly history

Bio Key International revenue by quarterBio Key International revenue by quarter$1.5MQ4 2024$1.6MQ1 2025$1.7MQ2 2025$1.5MQ3 2025$1.1MQ4 2025$2.1MQ1 2026$1.9MQ2 2026
Bio Key International net earnings by quarterBio Key International net earnings by quarter−$1.4MQ4 2024−$737KQ1 2025−$1.2MQ2 2025−$965KQ3 2025−$4.3MQ4 2025−$205KQ1 2026−$577KQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 13, 2026$1.9M+13%-27.6%−$577K−$846K
Q1 202610-QJun 22, 2026$2.1M+34%-7.4%−$205K−$358K
Q4 202510-KJun 12, 2026$1.1M-26%-388.5%−$4.3M−$1.8M
Q3 202510-QNov 14, 2025$1.5M-28%-57.6%−$965K−$1.1M
Q2 202510-QAug 13, 2025$1.7M+49%-63.9%−$1.2M−$880K
Q1 202510-QMay 15, 2025$1.6M-26%-39.9%−$737K−$835K
Q4 202410-KApr 23, 2025$1.5M-20%-86.7%−$1.4M−$515K

Charts

Bio Key International: revenue growth, year over year and quarter over quarterBio Key International: revenue growth, year over year and quarter over quarterY/YQ/Q-20%Q4 2024-26%+10%Q1 2025+49%+6%Q2 2025-28%-9%Q3 2025-26%-30%Q4 2025+34%+98%Q1 2026+13%-11%Q2 2026
Latest (Q2 2026): Y/Y +13%, Q/Q -11%.
Bio Key International: where the cash came from (+) and went (−), TTM to Q2 2026Bio Key International: where the cash came from (+) and went (−), TTM to Q2 2026Operating cash flow−$4.2MOther financing$2.4MNet borrowing (+) / repaid (−)$1.0MCash drawn (+) / kept (−)$896KExchange rates−$121KCapital spending−$6K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Bio Key International: profit against cash, quarter by quarterBio Key International: profit against cash, quarter by quarterNet incomeOperating cash flow−$739K−$1.3MQ3 2024−$1.4M−$515KQ4 2024−$737K−$835KQ1 2025−$1.2M−$880KQ2 2025−$965K−$1.1MQ3 2025−$4.3M−$1.8MQ4 2025−$205K−$358KQ1 2026−$577K−$846KQ2 2026
Latest (Q2 2026): Net income −$577K, Operating cash flow −$846K.
Bio Key International in its industry: growth against margin (192 companies, SIC 7372)Bio Key International in its industry: growth against margin (192 companies, SIC 7372)revenue growth, year over year →↑ operating marginmedian +12%median 0%MSFTORCLCRMADBEXYZINTUNOWSHOPCRWVSNPSPLTRADSKElectronic Arts Inc.TEAMSSNCCDNSRBLXTWLOSNOWTTWOCRWDGENDDOGHUBSVEEVDOCUOKTANETMDBNTNXPTCTYLDBXUDTPAYCMBLYESTCPCTYZETARBRKACIWBSYGWREPATHPCORTDCOCTVFIGKVYOCOURBILLBOXCVLTDUOLSAILGTMMANHLIMEAPPFCCCYOUTTANBLKBSGTLBALRMTENBWKPRGSFRSHAPPNBANDNAVNBRZEQTWONTSKASANCXMVERXRPDSPSCBLFSLYVRNSQLYSFROGMQBBINTANCNOEVCMNABLVIAALKTAVPTSPTPDGDYNXPERAMPLDDDSKILCERTCCSICMRCMKTWHUCKCRNCPDFSWEAVSOUNINSEXZODHIIIVLiveperson IncAIMRDNMYPSUPLDKLTRBLZELAWDRTTFBBAIMAPSCCLDEXFYRDVTSSTIEGANNTWKRCATSNALFDCTSVCOMCHXAEYEZDGEADBTWFCFAISPDUOTIDNPDYNQUBTZSPCROCFATNAWRESMSIINLXBLINMSGMGEGSEGGMYSZCXAIGXAIPARAAITXCYABAPCXSPAIDSNYEXYNIDAIATDSIVDAVPRBSKKYUMEWAIFFAUIDGlobal Arena Holding, Inc.ATHRVIDAQXLLIVGUPYYFNGRSVMBTransparentBusiness, Inc.SWMRAMSTTransit Pro Tech Inc.PXLWDNKCDPLSGYGYBKYI (+13%, -28%)
Services-Prepackaged Software; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Bio Key International

Solely for convenience, trademarks and tradenames referred to in this Annual Report on Form 10-K appear (after the first usage) without the ® and ™ symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trademarks and tradenames. BIO-key International, Inc. (the “Company,” “BIO-key,” “we,” or “us”) is a leading identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA).

In its own words, from its 10-K, filed Jun 12, 2026.

Bio Key International against its Services-Prepackaged Software peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +13% against the peers' median +14%. Operating margin: -27.6% against the peers' median 15.2%.

CompanyQuarterRevenueY/YOp. margin
BKYI Bio Key InternationalQ2 2026$1.9M+13%-27.6%
MSFT MicrosoftQ1 FY27$92.3B+19%49.8%
ORCL OracleQ1 FY27$19.3B+30%34.8%
CRM SalesforceQ2 FY27$11.3B+11%20.5%
ADBE AdobeQ3 FY26$6.8B+13%34.8%
XYZ BlockQ3 2026$6.7B+10%6.4%
INTU IntuitQ4 FY26$4.4B+14%10.9%
NOW ServiceNowQ3 2026$4.1B+20%9.4%
SHOP ShopifyQ3 2026$3.7B+32%15.2%

Source: Bio Key International 10-Q on SEC EDGAR · CIK 1019034 · Services-Prepackaged Software

More on BKYI

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare BKYI with

中文版:Bio Key International(BKYI)财报

Español · Français